OtherClinical Investigations (Human)
Molecular signature of FDG-PET biomarkers in newly diagnosed multiple myeloma patients: a genome-wide transcriptome analysis from the CASSIOPET study
Jean-Baptiste Alberge, Francoise Kraeber-Bodere, Bastien Jamet, Cyrille Touzeau, Helene Caillon, Soraya Wuilleme, Marie-Christine Bene, Tobias Kampfenkel, Pieter Sonneveld, Mark Van Duin, Herve Avet-Loiseau, Jill Corre, Florence Magrangeas, Thomas Carlier, Caroline Bodet-Milin, Michel Cherel, Philippe Moreau, Stephane Minvielle and Clement Bailly
Journal of Nuclear Medicine January 2022, jnumed.121.262884; DOI: https://doi.org/10.2967/jnumed.121.262884
Jean-Baptiste Alberge
1 Nantes University, CHU Nantes, CNRS, Inserm, CRCINA, 44000 Nantes, France;
Francoise Kraeber-Bodere
1 Nantes University, CHU Nantes, CNRS, Inserm, CRCINA, 44000 Nantes, France;
Bastien Jamet
2 Nuclear Medicine Unit, University Hospital, 44093 Nantes, France;
Cyrille Touzeau
1 Nantes University, CHU Nantes, CNRS, Inserm, CRCINA, 44000 Nantes, France;
Helene Caillon
3 Haematology Department, University Hospital, 44093 Nantes, France;
Soraya Wuilleme
3 Haematology Department, University Hospital, 44093 Nantes, France;
Marie-Christine Bene
3 Haematology Department, University Hospital, 44093 Nantes, France;
Tobias Kampfenkel
4 Janssen Research & Development, LLC, Leiden;
Pieter Sonneveld
5 Erasmus University Medical Center Cancer Institute, Rotterdam, Netherlands;
Mark Van Duin
5 Erasmus University Medical Center Cancer Institute, Rotterdam, Netherlands;
Herve Avet-Loiseau
6 Unit for Genomics in Myeloma, Institut Universitaire du Cancer de Toulouse-Oncopole, University Hospital, 31059 Toulouse, France;
Jill Corre
6 Unit for Genomics in Myeloma, Institut Universitaire du Cancer de Toulouse-Oncopole, University Hospital, 31059 Toulouse, France;
Florence Magrangeas
1 Nantes University, CHU Nantes, CNRS, Inserm, CRCINA, 44000 Nantes, France;
Thomas Carlier
1 Nantes University, CHU Nantes, CNRS, Inserm, CRCINA, 44000 Nantes, France;
Caroline Bodet-Milin
1 Nantes University, CHU Nantes, CNRS, Inserm, CRCINA, 44000 Nantes, France;
Michel Cherel
1 Nantes University, CHU Nantes, CNRS, Inserm, CRCINA, 44000 Nantes, France;
Philippe Moreau
1 Nantes University, CHU Nantes, CNRS, Inserm, CRCINA, 44000 Nantes, France;
Stephane Minvielle
1 Nantes University, CHU Nantes, CNRS, Inserm, CRCINA, 44000 Nantes, France;
Clement Bailly
7 Nantes University, CHU Nantes, CNRS, Inserm, CRCINA, France

Article Figures & Data
Additional Files
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 66, Issue 2
February 1, 2025
Molecular signature of FDG-PET biomarkers in newly diagnosed multiple myeloma patients: a genome-wide transcriptome analysis from the CASSIOPET study
Jean-Baptiste Alberge, Francoise Kraeber-Bodere, Bastien Jamet, Cyrille Touzeau, Helene Caillon, Soraya Wuilleme, Marie-Christine Bene, Tobias Kampfenkel, Pieter Sonneveld, Mark Van Duin, Herve Avet-Loiseau, Jill Corre, Florence Magrangeas, Thomas Carlier, Caroline Bodet-Milin, Michel Cherel, Philippe Moreau, Stephane Minvielle, Clement Bailly
Journal of Nuclear Medicine Jan 2022, jnumed.121.262884; DOI: 10.2967/jnumed.121.262884
Molecular signature of FDG-PET biomarkers in newly diagnosed multiple myeloma patients: a genome-wide transcriptome analysis from the CASSIOPET study
Jean-Baptiste Alberge, Francoise Kraeber-Bodere, Bastien Jamet, Cyrille Touzeau, Helene Caillon, Soraya Wuilleme, Marie-Christine Bene, Tobias Kampfenkel, Pieter Sonneveld, Mark Van Duin, Herve Avet-Loiseau, Jill Corre, Florence Magrangeas, Thomas Carlier, Caroline Bodet-Milin, Michel Cherel, Philippe Moreau, Stephane Minvielle, Clement Bailly
Journal of Nuclear Medicine Jan 2022, jnumed.121.262884; DOI: 10.2967/jnumed.121.262884